Food Allergy Diagnosis & Treatment Market By Product, End User, And Marketing Channels & Forecast To

By Author: Market Research Future
Total Articles: 147
Comment this article

Market Overview and Growth Factors:

In the diagnosis segment, secondary diagnosis steps such as Polymerase Chain Reaction (PCR), Enzyme-linked ImmunoSorbent Assay (ELISA), and others are expected to garner larger market share in comparison to primary diagnosis steps which includes skin prick test, blood test, food elimination diet test, and others. The major factor responsible for the market growth is the growing awareness regarding food-borne allergies and their expensive screening costs.

The Food Allergy Diagnosis & Treatment Market is estimated to be valued at USD 18,083.2 million by 2023 and expected to grow at a CAGR of 3.14% during the forecast period. Among food source, the seafood segment accounted for the largest market share. However, milk food source segment has been projected to grow at the highest CAGR on account of increasing cases of lactose intolerance in Europe and North America.

However, the only bottleneck in the growth trajectory of the global food allergy diagnosis and treatment market are the lack of skilled technical workforce and limitations associated with ELISA testing, such ...
... as false positive result, resulting in recurring cost.

Key Players:

The prominent players in the global food allergy diagnosis & treatment market are SGS S.A. (Switzerland), Intertek Group PLC (UK), TÜV SÜD AG (Singapore), ALS Limited (Australia), Eurofins Scientific SE (Luxembourg), Mérieux NutriSciences Corporation (US), AsureQuality Limited (New Zealand), and Microbac Laboratories, Inc. (US).

Key Findings of the Study:

The global food allergy diagnosis and treatment market is expected to reach USD 18,083.2 million by 2023 from US D 14,849.5 million in 2019 and is expected to register a CAGR of 3.41% during the forecast period from 2019 to 2023.
In 2019, the market was led by the Americas with a 50.79% share, followed by Europe and Asia-Pacific
On the basis of food source, the seafood segment accounted for the largest market share of 21.86% in 2019. The milk segment is expected to account for the highest CAGR of 3.87% during the forecast period.
The ELISA category accounted for the largest market share in the global level with a value of USD 5,240.7 million in 2019.
On the basis of treatment, the antihistamines segment accounted for the largest market share of 82.0% in 2019.
On the basis of end use the diagnostic centers segment valued at USD 10,612.8 million in 2019.
This research report provides insights into various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Food Allergy Diagnosis & Treatment Market, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.

Segment analysis:

The Global Food Allergy Diagnosis & Treatment Market has been segmented on the basis of food source, diagnosis, treatment, end-use, and region. On the basis of food source, the market has been divided into eggs, milk, Food Allergy Diagnosis & Treatment, seafood, tree nuts, wheat, soy, and others. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Milk allergy is most common in infants and children; however, it can develop at any age. Food Allergy Diagnosis & Treatment are the most common cause of food allergy. Tree nuts include almonds, walnuts, hazelnuts, pine nuts, pecans, and lychee nuts, among others. Wheat allergy is an allergic reaction caused by the consumption of wheat and food containing wheat. Soy allergy mainly starts in infancy with reaction to soy-based infant formula. Milk segment is projected to grow at the highest CAGR of 3.87% during the forecast period.

Based on diagnosis, the global food allergy diagnosis & treatment market is segmented into primary and secondary. The primary segment includes—skin prick test, blood test, food elimination diet test, and others. This segment is expected to grow at a CAGR of 3.40% over the forecast period.

The secondary methods of food allergy diagnosis are included such as Polymerase Chain Reaction (PCR) methods, Enzyme-Linked Immunosorbent Assay (ELISA) method, and others. If food allergy detection fails through ELISA, PCR method is used to detect the allergen. PCR segment is projected to grow at a CAGR of 3.68% over the forecast period. ELISA is a sensitive method to test the presence of the antigen. This segment is estimated to grow at a CAGR of 2.57% over the forecast period.

On the basis of treatment, the global food allergy diagnosis & treatment market is segmented into antihistamines and adrenalin & corticosteroids. Antihistamines & corticoids segment is projected to grow at the highest CAGR of 3.42% over the forecast period while adrenalin segment is expected to grow at a CAGR of 3.39% over the forecast period.

By end-use, global food allergy diagnosis & treatment market has been segmented into hospitals & clinics, diagnostic centers, and research institutes. The hospital & clinics segment accounted for the larger market share of 71.5% in 2019. However, the diagnostic centers segment is projected to exhibit a higher CAGR of 3.47%.

Browse More Information @ https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562

Regional Analysis

Geographically, the global Food Allergy Diagnosis & Treatment Market is segmented into Asia-Pacific, Europe, Americas, and the Middle East & Africa. As per MRFR analysis, Americas dominated the market, accounted for the largest share of the market in 2019, and expected to grow at a CAGR of 2.93%. Americas market is followed by Europe, which is accounting for the second largest number of shares in the global food allergy diagnosis & treatment market, as of 2019. Europe is estimated to reach USD 6,826.4 million by the end of 2023. Asia-Pacific is expected to have the largest market share during the forecast period and is also expected to grow with the highest CAGR of 4.56%, in 2019.